Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients

American Journal of Cardiology

Volumn 112, Issue 5, 2013, Pages 684-687

  Deftereos, Spyridon ^a   Giannopoulos, Georgios ^a   Kossyvakis, Charalampos ^a   Efremidis, Michael ^b   Panagopoulou, Vasiliki ^a   Raisakis, Konstantinos ^a   Kaoukis, Andreas ^a   Karageorgiou, Sofia ^a   Bouras, Georgios ^a   Katsivas, Apostolos ^c   Pyrgakis, Vlasios ^a   Stefanadis, Christodoulos ^d  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c RED CROSS HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MOXONIDINE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; CROSSOVER PROCEDURE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP DISORDER; SYMPATHETIC BLOCKING; SYMPATHETIC TONE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; XEROSTOMIA;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; PROPAFENONE; SOTALOL; SYMPATHOLYTICS; TREATMENT OUTCOME;

EID: 84881611721     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.04.049     Document Type: Article

References (14)

1. P.S. Chen, and A.Y. Tan Autonomic nerve activity and atrial fibrillation Heart Rhythm 4 2007 S61 S64
2. O.F. Sharifov, V.V. Fedorov, G.G. Beloshapko, A.V. Glukhov, A.V. Yushmanova, and L.V. Rosenshtraukh Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs J Am Coll Cardiol 43 2004 483 490
3. A.Y. Tan, S. Zhou, G. Gholmieh, M. Ogawa, A. De Silva, A. Garfinkel, H.S. Karagueuzian, L.S. Chen, and P.S. Chen Spontaneous autonomic nerve activity and paroxysmal atrial tachyarrhythmias (abstract) Heart Rhythm 3 1S 2006 S184
4. M.J. Shen, E.K. Choi, A.Y. Tan, S.F. Lin, M.C. Fishbein, L.S. Chen, and P.S. Chen Neural mechanisms of atrial arrhythmias Nat Rev Cardiol 9 2011 30 39
5. D. Linz, F. Mahfoud, U. Schotten, C. Ukena, H.R. Neuberger, K. Wirth, and M. Böhm Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea Hypertension 60 2012 172 178
6. E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J.S. Steinberg A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension J Am Coll Cardiol 60 2012 1163 1170
7. P. Coumel, P. Attuel, J. Lavallee, D. Flammang, J.F. Leclercq, and R. Slama The atrial arrhythmia syndrome of vagal origin Arch Mal Coeur Vaiss 71 1978 645 656
8. J.L. Huang, Z.C. Wen, W.L. Lee, M.S. Chang, and S.A. Chen Changes of autonomic tone before the onset of paroxysmal atrial fibrillation Int J Cardiol 66 1998 275 283
9. M. Zimmermann, and D. Kalusche Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins J Cardiovasc Electrophysiol 12 2001 285 291
10. M. Bettoni, and M. Zimmermann Autonomic tone variations before the onset of paroxysmal atrial fibrillation Circulation 105 2002 2753 2759
11. D. Amar, H. Zhang, S. Miodownik, and A.H. Kadish Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation J Am Coll Cardiol 42 2003 1262 1268
12. L.P. Edwards, T.A. Brown-Bryan, L. McLean, and P. Ernsberger Pharmacological properties of the central antihypertensive agent, moxonidine Cardiovasc Ther 30 2012 199 208
13. V. Kühlkamp, A. Schirdewan, K. Stangl, M. Homberg, M. Ploch, and O.A. Beck Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 36 2000 139 146
14. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, F.H. Rutten, and ESC Committee for Practice Guidelines Guidelines for the management of atrial fibrillation Europace 12 2010 1360 1420